Optum Rx, a subsidiary of UnitedHealth Group, is keeping close tabs on three drug candidates that might be approved in the next few months, according to its fall 2023 report.
Read the full post on Becker's Hospital Review - Healthcare News
3 drugs nearing approval to know: Optum
